Proteomics Intl Labs Ltd has released a press release.
Appendix 4C - corrected
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- Appendix 4C - June 2017 Quarterly Report
- Proteomics wins major analytical services contract
- Response to ASX Query
- Clinical validation study confirms PromarkerD performance
- World leading laboratory launches clinical trials testing
Later from Proteomics International Laboratories
- US PromarkerD patent expanded to all kidney disease
- PromarkerD predictive test results published - Diabetes Care
- Proteomics receives R&D tax incentive
- Appendix 4C - September 2017 Quarterly Report
- Proteomics partnered consortium to receive $2 million
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories